Bionano Genomics股价因第一季度收入下滑而上涨

Bionano Genomics (NASDAQ:BNGO) shares jumped in post market trading on Wednesday after it reported its first quarter revenue above expectations.

The company posted first quarter revenue of $6.46M, beating consensus of $6.25M.

“The first quarter of 2025 represents the first full quarter of execution after shifting strategy towards a focus on our base of routine users of optical genome mapping (OGM) and VIA software as the primary drivers of our revenue and gross profit," Erik Holmlin, chief executive officer, said in a statement.

Bionano, however, lowered full year revenue expectation between the range of $26M and $30M, compared to the previous range between $29M and $32M.

The stock of the company is up about 31% after the bell.